華潤三九(000999.SZ):鋁碳酸鎂咀嚼片、阿奇黴素片擬中選全國藥品集中採購
格隆匯1月17日丨華潤三九(000999.SZ)公佈,2020年1月17日,公司全資子公司廣東華潤順峯藥業有限公司(“順峯藥業”)、浙江華潤三九眾益製藥有限公司(“眾益製藥”)參加了國家組織藥品集中採購和使用聯合採購辦公室組織的第二批國家藥品集中採購工作。順峯藥業的藥品鋁碳酸鎂咀嚼片(0.5g)、眾益製藥的藥品阿奇黴素片(0.25g)擬中選此次集中採購。
其中,鋁碳酸鎂咀嚼片(0.5g)的擬中選價為7.26元/盒;阿奇黴素片(0.25g)的擬中選價為6.13元/盒。
公司此次擬中選品種為鋁碳酸鎂咀嚼片、阿奇黴素片,若後續簽訂採購合同並實施,將有利於上述產品擴大其市場覆蓋和銷售,提升市場競爭力,對公司未來經營業績產生積極的影響。
此次國家組織藥品集中採購和使用工作,由全國各省份和新疆生產建設兵團組成採購聯盟,聯盟集中採購產生結果後,即在全國範圍同步實施,在執行上要求確保中選藥品質量、供應、採購使用和及時回款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.